Surgical techniques and oncological outcomes of pure transperitoneal laparoscopic radical nephroureterectomy for upper urinary tract urothelial carcinoma

被引:1
|
作者
Yuan, Changwei [1 ]
Xu, Chunru [1 ]
Li, Zhihua [1 ]
Meng, Chang [1 ]
Du, Yicong [1 ]
Zhang, Cuijian [1 ]
Fang, Dong [1 ]
Li, Xuesong [1 ]
Zhou, Liqun [1 ]
机构
[1] Peking Univ, Hosp 1, Inst Urol, Natl Urol Canc Ctr,Dept Urol, 8 St Xishiku, Beijing 100034, Peoples R China
关键词
Laparoscopic; single position; transperitoneal; nephroureterectomy; upper urinary tract urothelial carcinoma (UTUC); DISTAL URETER; BLADDER-CUFF; MANAGEMENT; RECURRENCE;
D O I
10.21037/tau-22-653
中图分类号
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
摘要
Background: Open radical nephroureterectomy (RNU) with bladder cuff excision is the standard treatment for upper urinary tract urothelial carcinoma (UTUC). Traditional laparoscopic radical nephroureterectomy (LSRNU) is not minimally invasive enough due to the complex surgical procedure. This study aims to discuss the clinical feasibility and oncological outcomes of pure transperitoneal LSRNU for UTUC.Methods: Between July 2010 and December 2020, 115 patients were admitted to the hospital with the diagnosis of UTUC treated with pure LSRNU by one surgeon. A special laparoscopic bulldog clamp was placed at the bladder cuff before cutting and suturing. The clinical and follow-up data were preoperatively collected and analyzed. Overall survival (OS) and cancer-specific survival (CSS) were estimated by the Kaplan-Meier method.Results: All surgeries were completed uneventfully in this cohort. The mean operative time was 145.69 minutes. The mean estimated blood loss was 56.61 mL. The mean removal time of the drain was 3.46 days. The mean time of having liquid diet was 1.32 days, and the ambulation time was 1.50 days. All surgeries were effectively completed, and no case required open conversion. According to the ClavienDindo classification system, postoperative complications occurred in two patients (II, III). The mean length of postoperative hospital stay was 5.78 days. The mean follow-up duration was 54.50 months. Recurrence in the bladder was 16.0% (15/94), compared with 4.6% (4/87) in the contralateral upper tract. The 5-year OS and CSS rates were 78.9% and 81.4%, respectively.Conclusions: Pure transperitoneal LSRNU is a safe and effective minimally invasive technology for the treatment of UTUC.
引用
收藏
页码:952 / 959
页数:8
相关论文
共 50 条
  • [31] Oncologic outcomes of laparoscopic nephroureterectomy for pT3 upper urinary tract urothelial carcinoma
    Lee, J. N.
    Kim, B. S.
    Kim, H. T.
    Kim, T. -H.
    Yo, E. S.
    Choi, G. -S.
    Kim, B. W.
    Kwon, T. G.
    MINERVA UROLOGICA E NEFROLOGICA, 2014, 66 (03) : 157 - 164
  • [32] The Impact of Surgical Waiting Time on Oncological Outcomes in Patients with Upper Tract Urothelial Carcinoma Undergoing Radical Nephroureterectomy: A Systematic Review
    Nowak, Lukasz
    Krajewski, Wojciech
    Laszkiewicz, Jan
    Malkiewicz, Bartosz
    Chorbinska, Joanna
    Del Giudice, Francesco
    Mori, Keiichiro
    Moschini, Marco
    Kaliszewski, Krzysztof
    Rajwa, Pawel
    Laukhtina, Ekaterina
    Shariat, Shahrokh F.
    Szydelko, Tomasz
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (14)
  • [33] Perioperative and oncologic outcomes of transperitoneal versus retroperitoneal laparoscopic nephroureterectomy for upper urinary tract urothelial carcinoma: a systematic review and pooled analysis of comparative outcomes
    Ping-yu Zhu
    Li Wang
    Kun-peng Li
    Shan Yin
    Xiao-bin Chen
    World Journal of Surgical Oncology, 21
  • [34] Perioperative and oncologic outcomes of transperitoneal versus retroperitoneal laparoscopic nephroureterectomy for upper urinary tract urothelial carcinoma: a systematic review and pooled analysis of comparative outcomes
    Zhu, Ping-yu
    Wang, Li
    Li, Kun-peng
    Yin, Shan
    Chen, Xiao-bin
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2023, 21 (01)
  • [35] Transperitoneal versus retroperitoneal laparoscopic nephroureterectomy in the management of upper urinary tract urothelial carcinoma: a matched-pair comparison based on perioperative outcomes
    Wentao Liu
    Yinhuai Wang
    Zhaohui Zhong
    Hongyi Jiang
    Shifeng Ouyang
    Liang Zhu
    Ran Xu
    Surgical Endoscopy, 2016, 30 : 5537 - 5541
  • [36] Surgical and oncological outcomes of robot-assisted versus laparoscopic radical nephroureterectomy for upper-tract urothelial carcinoma: A single-center comparative analysis
    Vasudeo, Vivek
    Singh, Amitabh
    Khanna, Ashish
    Rawal, Sudhir Kumar
    Pratihar, Sarbartha Kumar
    Saurabh, Nikhil
    Kumar, Bhuwan
    Ali, Mujahid
    Sharma, Prerit
    Akotkar, Shravika
    Sharma, Girish
    Kesarwani, Bhagyashri
    INDIAN JOURNAL OF UROLOGY, 2023, 39 (04) : 285 - 291
  • [37] Transperitoneal versus retroperitoneal laparoscopic nephroureterectomy in the management of upper urinary tract urothelial carcinoma: a matched-pair comparison based on perioperative outcomes
    Liu, Wentao
    Wang, Yinhuai
    Zhong, Zhaohui
    Jiang, Hongyi
    Ouyang, Shifeng
    Zhu, Liang
    Xu, Ran
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2016, 30 (12): : 5537 - 5541
  • [38] PERIOPERATIVE OUTCOMES OF LAPAROSCOPIC RADICAL NEPHROURETERECTOMY AND REGIONAL LYMPHADENECTOMY IN PATIENTS WITH UPPER URINARY TRACT UROTHELIAL CARCINOMA AFTER NEOADJUVANT CHEMOTHERAPY
    Rajput, M. Z.
    Kamat, A. M.
    Clavell-Hernandez, J.
    Siefker-Radtke, A. O.
    Grossman, H. B.
    Dinney, C. P.
    Matin, S. F.
    EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 82 - 83
  • [39] PERIOPERATIVE OUTCOMES OF LAPAROSCOPIC RADICAL NEPHROURETERECTOMY AND REGIONAL LYMPHADENECTOMY IN PATIENTS WITH UPPER URINARY TRACT UROTHELIAL CARCINOMA AFTER NEOADJUVANT CHEMOTHERAPY
    Rajput, Mohamed
    Kamat, Ashish
    Clavell-Hernandez, Jonathan
    Siefker-Radtke, Arlene
    Grossman, H. Barton
    Dinney, Colin
    Matin, Surena
    JOURNAL OF UROLOGY, 2011, 185 (04): : E200 - E200
  • [40] Preoperative chronic kidney disease predicts poor oncological outcomes after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma
    Kodama, Hirotake
    Hatakeyama, Shingo
    Fujita, Naoki
    Iwamura, Hiromichi
    Anan, Go
    Fukushi, Ken
    Narita, Takuma
    Tanaka, Toshikazu
    Kubota, Yuka
    Horiguchi, Hirotaka
    Momota, Masaki
    Kido, Koichi
    Matsumoto, Teppei
    Soma, Osamu
    Hamano, Itsuto
    Yamamoto, Hayato
    Tobisawa, Yuki
    Yoneyama, Tohru
    Yoneyama, Takahiro
    Hashimoto, Yasuhiro
    Koie, Takuya
    Ito, Hiroyuki
    Yoshikawa, Kazuaki
    Sasaki, Atsushi
    Kawaguchi, Toshiaki
    Sato, Makoto
    Ohyama, Chikara
    ONCOTARGET, 2017, 8 (47) : 83183 - 83194